Ali Hariri
Directeur Technique/Scientifique/R&D chez ELOXX PHARMACEUTICALS, INC.
Provenance du réseau au premier degré de Ali Hariri
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.
20
| Subsidiary | Medical Specialties | 20 |
| Public Company | Biotechnology | 14 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Ali Hariri via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Zikani Therapeutics, Inc.
 Zikani Therapeutics, Inc. Drugstore ChainsRetail Trade Zikani Therapeutics, Inc. is a preclinical-stage company developing and commercializing novel therapeutics. The company was founded by Lawrence G. Miller and Andrew G. Myers in 2014 and is headquartered in Watertown, MA. | Drugstore Chains | Director of Finance/CFO Director/Board Member Chairman Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Eloxx Pharmaceuticals Ltd.
 Eloxx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Eloxx Pharmaceuticals Ltd. provides biopharmaceutical research and development services. The firm specializes in the discovery, development, and commercialization of drug compounds for the treatment of genetic diseases. It focuses on the treatment of diseases caused by nonsense mutations, including Cystic fibrosis, Duchene Muscular Dystrophy, Usher syndrome, Ataxia-telangiectasia, Beta thalassemia, and Tay-Sachs Hurler syndrome. Its focus areas encompass clinical drug development and target drugs discovery programs. The company was founded by Silvia Noiman and Shmuel Tuvia in 2013 and is headquartered in Herzliya, Israel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| KEROS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member | |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer General Counsel Corporate Officer/Principal | |
| VBI VACCINES INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Artax Biopharma, Inc.
 Artax Biopharma, Inc. Medical SpecialtiesHealth Technology Artax Biopharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of new therapies for autoimmune and inflammatory diseases. The firm develops drugs targeting the interaction between T-cell Receptors (TCR) and Nck, a cytoplasmic adapter protein which plays a role in T-cell activation. The company was founded by Dami? Carulla Tormo in 2013 and is headquartered in Cambridge, MA. | Medical Specialties | Director of Finance/CFO Director/Board Member Director/Board Member | |
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Private Equity Investor | |
| BLUEPRINT MEDICINES CORPORATION | Biotechnology | Compliance Officer Chief Operating Officer | |
Syntimmune, Inc.
 Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | Biotechnology | President Corporate Officer/Principal | |
CalciMedica, Inc. (US)
 CalciMedica, Inc. (US) BiotechnologyHealth Technology CalciMedica, Inc. is a holding company, which engages in drug development. It discovers and develops novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The company was founded by Gonul Velicelebi, Kenneth Stauderman, Anjana Rao, Patrick Hogan, Stefan Feske, Michael Harpold, Tom Reed, and Jack Roos in December 2006 and is headquartered in La Jolla, CA. | Biotechnology | Director of Finance/CFO Director/Board Member | |
Advent Life Sciences LLP
 Advent Life Sciences LLP BiotechnologyHealth Technology Part of Advent Venture Partners LLP, Advent Life Sciences LLP is a venture capital firm for visionary innovators. The company is based in London, UK. Advent Life Sciences has achieved its first discovery milestone in collaboration with Bristol Myers Squibb, and is focused on the journey from innovative science to an approved medicine or product. The British company has a history of delivering value and is one of the leading venture capital firms in the industry. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| SAREPTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| AURA BIOSCIENCES, INC. | Biotechnology | Director/Board Member Chairman | |
Arrakis Therapeutics, Inc.
 Arrakis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arrakis Therapeutics, Inc. operates as a biopharmaceutical company. It develops rna-targeted small molecule medicines focused on neurologic, cancer, and rare genetic diseases. The company was founded by Russell C. Petter, Alan E. Walts, Jennifer C. Petter and Raj Bhikhu Parekh in 2015 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Founder Founder | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Director/Board Member | |
PIC Therapeutics, Inc.
 PIC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology PIC Therapeutics, Inc. operates as a biotechnology company, which focuses on transforming the treatment of cancer though the selective modulation of oncogene translation. The company was founded by Richard Peters and Gerhard Wagner and is headquartered in Boston, MA. | Pharmaceuticals: Major | Chairman Founder | |
CathWorks Ltd.
 CathWorks Ltd. Medical SpecialtiesHealth Technology CathWorks Ltd. develops medical devices for the interventional cardiology market. Its technology is based on processing visual information and automatic multi-layered algorithms. The company was founded by Guy Lavi and Ifat Lavi in 2013 and is headquartered in Raanana, Israel. | Medical Specialties | Director/Board Member Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
CollPlant Ltd.
 CollPlant Ltd. BiotechnologyHealth Technology CollPlant Ltd. specializes in the development and commercialization of medical products. It develops and commercialize tissue repair products for orthobiologics and advanced wound care markets. The company was founded by Tsafrir Feigin Yehuda and Oded Shoseyov in 2004 and is headquartered in Ness Ziona, Israel. | Biotechnology | Director/Board Member Director/Board Member | |
| Pontifax Management 4 Gp 2015 Ltd. | Corporate Officer/Principal Corporate Officer/Principal | ||
Fore Biotherapeutics, Inc.
 Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Pontifax (Israel) IV LP
 Pontifax (Israel) IV LP Financial ConglomeratesFinance Part of Pontifax Management Co. Ltd., Pontifax (Israel) IV LP is an investment services provider. The company is based in Hertsliya, Israel and was founded in 2015. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| COLLPLANT BIOTECHNOLOGIES LTD. | Medical Specialties | Director/Board Member Director/Board Member | |
| SCISPARC LTD. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Raziel Therapeutics RT Ltd.
 Raziel Therapeutics RT Ltd. Pharmaceuticals: MajorHealth Technology Raziel Therapeutics RT Ltd. develops innovative technology to treat obesity disease. It is developing RZL-12, is a potential first-in-class, injectable drug for the reduction of fat cell mass. the firm developed a novel drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into brown adipose tissue-like. The company was founded by Shmuel A. Ben-Sasson in 2012 and is headquartered in Jerusalem, Israel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| RHYTHM PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
| ERECH FINANCE CAHALACHA LTD | Medical Specialties | Director/Board Member Director/Board Member | |
Nutrinia Ltd.
 Nutrinia Ltd. Pharmaceuticals: MajorHealth Technology Nutrinia Ltd. develops bioactive feed supplements for infant formulas and animal feed. The firm is involved in broad intellectual property protection, industrial processes envelopment, conducting additional clinical trials and obtaining regulatory approval for the supplementation of pre-term and infant formulas with Insulin. The company was founded by Naim Shehadeh in 2003 and is headquartered in Ramat-Gan, Israel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Graduate Degree | |
| CALLIDITAS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Pontifax Management Co. Ltd.
 Pontifax Management Co. Ltd. Investment ManagersFinance Pontifax Management Co. Ltd. (Pontifax) is a venture capital firm founded in 2004 by Eliyahu Hurvitz. The firm is headquartered in Herzliya Pituach, Israel. | Investment Managers | Chief Executive Officer Founder | |
| TREVI THERAPEUTICS, INC. | Biotechnology | Chairman Corporate Officer/Principal | |
Genzyme Europe BV
 Genzyme Europe BV Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Europe BV is a Dutch company that develops and manufactures pharmaceutical and biotherapeutic products. The company is based in Amsterdam, Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Aliment Capital Llc
 Aliment Capital Llc Investment ManagersFinance Aliment Capital LLC (Aliment Capital) is a venture capital subsidiary of Pontifax Management Co. Ltd. founded in 2014 by Philip Robert Erlanger and Ben Belldegrun. The firm is headquartered in California, United States. | Investment Managers | Consultant / Advisor Consultant / Advisor | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | General Counsel Private Equity Investor | |
| Groupe de Sup de Co La Rochelle | College/University | Graduate Degree | |
Hoffman-LaRoche F & Co. AG
 Hoffman-LaRoche F & Co. AG Miscellaneous Commercial ServicesCommercial Services Hoffman-LaRoche F & Co. AG is a Swiss company. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Zhejiang University | College/University | Undergraduate Degree | |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MIT Sloan School of Management | College/University | Masters Business Admin | |
Bit Bio Ltd.
 Bit Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Bit Bio Ltd. engages in research and experimental development on natural sciences and engineering. Its products are human-induced skeletal myocytes and glutamatergic neurons. The company was founded by Mark Kotter in 2016 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Chief Operating Officer | |
| MATINAS BIOPHARMA HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Maverick Therapeutics, Inc.
 Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | Biotechnology | Director/Board Member | |
| Shanghai Institute of Materia Medica Chinese Academy of Sci | College/University | Graduate Degree | |
| Massachusetts College of Pharmacy & Health Science | College/University | Undergraduate Degree | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Università degli Studi di Modena e Reggio Emilia | College/University | Doctorate Degree | |
| SYNDAX PHARMACEUTICALS, INC. | Biotechnology | Public Communications Contact |
Statistiques
Internationale
| Etats-Unis | 27 |
| Israël | 13 |
| Royaume-Uni | 5 |
| Chine | 3 |
| Suède | 2 |
Sectorielle
| Health Technology | 34 |
| Consumer Services | 9 |
| Finance | 6 |
| Commercial Services | 3 |
| Retail Trade | 2 |
Opérationnelle
| Director/Board Member | 244 |
| Corporate Officer/Principal | 76 |
| Independent Dir/Board Member | 66 |
| Director of Finance/CFO | 45 |
| Chairman | 40 |
Relations les plus connectées
| Insiders | |
|---|---|
| Daniel Geffken | 53 |
| Raj Bhikhu Parekh | 50 |
| Tomer Kariv | 46 |
| Ran Nussbaum | 38 |
| Steven Rubin | 36 |
| Hilde Furberg | 21 |
| Zafrira Avnur | 20 |
| David Meeker | 19 |
| Alan Walts | 17 |
| Richard Peters | 16 |
| Carlo Incerti | 14 |
| Gadi Veinrib | 13 |
| E. Sutherland | 12 |
| Kathryn Corzo | 11 |
| Parth Chakrabarti | 11 |
- Bourse
- Insiders
- Ali Hariri
- Connexions Sociétés
